Osteoporosis management in hematologic stem cell transplant recipients: Executive summary

BACKGROUND: Treatment advances have reduced the adverse events associated with hematopoietic stem cell transplant (HSCT) and led to an increased number of transplants performed. HSCT patients are living longer with concerns on long-term outcomes. Bone fragility and fracture are at the forefront for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Bone Oncol
Autors principals: Kendler, D.L., Body, J.J., Brandi, M.L., Broady, R., Cannata-Andia, J., Cannata-Ortiz, M.J., El Maghraoui, A., Guglielmi, G., Hadji, P., Pierroz, D.D., de Villiers, T.J., Ebeling, P.R., Rizzoli, R.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2021
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8095179/
https://ncbi.nlm.nih.gov/pubmed/33996429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2021.100361
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars